🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

7,387 results for “Le” Clear

  1. Celestone Cronodose suspensión inyectable, Plasma rich in growth factors

    Wuhan Createrna Science and Technology Co., Ltd

    Low back pain

    approved small molecule active

    1 trial

  2. Chemoembolization and Response-Dependent Resection

    The First People's Hospital of Lianyungang

    Resectable Hepatocellular Carcinoma Beyond Milan Criteria

    approved other active

    1 trial

  3. Chocolate PTA Balloon

    Blackmores Limited

    Atherosclerosis

    approved other active

    1 trial

  4. Cholecalciferol

    The First People's Hospital of Lianyungang

    Peritoneal Dialysis-associated Peritonitis

    approved small molecule active

    1 trial

  5. Cholecalciferol

    United Therapeutics Europe Ltd

    Crohn Disease

    approved other active

    1 trial

  6. Ciclesonide

    Takeda

    Allergic Rhinitis

    approved small molecule completed

    1 trial

  7. Cilostazol

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Disease

    approved small molecule active

    1 trial

  8. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved small molecule active

    1 trial

  9. Ciprofol

    The First People's Hospital of Lianyungang

    Postoperative Delirium (POD)

    approved small molecule active

    1 trial

  10. Ciprofol

    The First People's Hospital of Lianyungang

    ECMO Treatment

    approved small molecule active

    1 trial

  11. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  12. Cohort A will receive an initial load dose of 8mg/kg and a maintenance dose of 6mg/kg intravenously on the first day of every three weeks for a total of 4 doses

    The First People's Hospital of Lianyungang

    HER2 Positive Breast Cancer

    approved small molecule active

    1 trial

  13. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  14. Combination of antiplatelet drugs and anticoagulants for at least one month

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  15. Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial

  16. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  17. Copaxone

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    2 trials

  18. Cormeto 250 mg capsule molli

    Istituto Gentili S.r.l.

    patients with adrenal incidentalomas and subclinical/mild Cushing’s syndrome

    approved small molecule active

    1 trial

  19. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials

  20. CrossBoss Catheter

    United Therapeutics Europe Ltd

    Arteriosclerosis

    approved other completed

    1 trial

  21. Crushed ticagrelor followed by morphine

    COLLEGIUM PHARMACEUTICAL, INC

    Unstable Angina Pectoris

    approved small molecule completed

    2 trials

  22. Cufence 200 mg hard capsules

    Univar Solutions BV

    Wilson’s Disease

    approved small molecule active

    1 trial

  23. Cymbalta 30 mg hard gastro-resistant capsules, Vimpat 50 mg film-coated tablets

    Disc Medicine

    chemotherapy-induced neuropathic pain

    approved small molecule active

    1 trial

  24. Cytokine-induced killer cells+ FOLFOX4

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources